We audited seven derma pen factories last year. Three passed. Four showed issues ranging from missing calibration records to unlabeled raw material bins. The difference between a factory that passes audit and one that fails is not the equipment. It is the documented procedures and the operators adherence to them.
A microneedling device OEM with EO sterilization capability offers a significant advantage for brand owners targeting regulated markets. Ethylene oxide sterilization is the preferred method for needle cartridges because it penetrates packaging without damaging the needle geometry. A microneedling device OEM with EO sterilization can provide sterile, ready-to-use cartridges that eliminate the need for in-office sterilization by the clinician.
The validation process for EO sterilization requires a microbiological challenge test, a cycle parameter record, and a residual gas analysis. When selecting a microneedling device OEM with EO sterilization, verify that the sterilization facility is ISO 11135 certified. The cost of EO sterilization adds approximately 0.03 to 0.08 USD per unit depending on volume and packaging configuration.
A microneedling device OEM with EO sterilization capability reduces your liability because the sterility assurance level is documented and traceable.
Most OEM project delays come from incomplete specifications and unverified supplier claims. A structured qualification process that includes specification review, sample testing, and factory audit reduces these risks. tbphp provides OEM partners with detailed specification data and regulatory support.
